Allspring Global Investments
CPRX

Allspring Global Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Allspring Global Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-117,088
Closed -$2.91M – 1887
2026
Q1 		$2.91M Buy
117,088
+94,933
+428% +$2.26M ﹤0.01% 983
2025
Q4 		$513K Buy
22,155
+1,953
+10% +$43.5K ﹤0.01% 1365
2025
Q3 		$398K Sell
20,202
-205
-1% -$4.22K ﹤0.01% 1409
2025
Q2 		$432K Sell
20,407
-152,777
-88% -$3.61M ﹤0.01% 1386
2025
Q1 		$4.14M Sell
173,184
-244,148
-59% -$5.5M 0.01% 971
2024
Q4 		$8.71M Buy
417,332
+50,888
+14% +$1.09M 0.01% 805
2024
Q3 		$7.28M Buy
366,444
+217,956
+147% +$4.04M 0.01% 846
2024
Q2 		$2.3M Buy
148,488
+5,007
+3% +$77.9K ﹤0.01% 1139
2024
Q1 		$2.29M Sell
143,481
-11,753
-8% -$177K ﹤0.01% 1153
2023
Q4 		$2.61M Sell
155,234
-320,168
-67% -$4.38M ﹤0.01% 1108
2023
Q3 		$5.56M Sell
475,402
-48,676
-9% -$651K 0.01% 934
2023
Q2 		$7.04M Buy
524,078
+93,311
+22% +$1.34M 0.01% 892
2023
Q1 		$7.14M Buy
430,767
+12,873
+3% +$212K 0.01% 887
2022
Q4 		$7.77M Buy
417,894
+207,412
+99% +$3.19M 0.01% 857
2022
Q3 		$2.7M Sell
210,482
-575,082
-73% -$6.82M ﹤0.01% 1148
2022
Q2 		$5.51M Sell
785,564
-292,687
-27% -$2.15M 0.01% 963
2022
Q1 		$8.94M Buy
1,078,251
+634,522
+143% +$4.49M 0.01% 922
2021
Q4 		$3M Buy
+443,729
New +$2.92M ﹤0.01% 1351

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allspring Global Investments's CPRX Position: Q2 2026 in Review

Allspring Global Investments sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 117,088 shares — an estimated $2.91M sold.

Allspring Global Investments first reported a position in CPRX in Q4 2021 and held it in 18 quarters. The position peaked at $8.94M in Q1 2022. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Allspring Global Investments reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Allspring Global Investments sold 117,088 Catalyst Pharmaceutical shares in Q2 2026, an estimated $2.91M.
  • Allspring Global Investments first reported a position in Catalyst Pharmaceutical in Q4 2021 and held it in 18 quarters.
  • Allspring Global Investments's Catalyst Pharmaceutical position peaked at $8.94M in Q1 2022.
  • 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.